SCHEMBL12247142

SCHEMBL12247142

CC1(C)c2ccccc2-c2cc3c(-c4ccc5ccccc5c4)c4ccccc4c(-c4ccc(-c5nc6ccccc6n5-c5ccccc5)cc4)c3cc21

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.39
ESR2 Q92731 2/20 0.39
MAPK10 P53779 3/20 0.38
RECQL P46063 1/20 0.37
PTGER4 P35408 1/20 0.37
GRIA1 P42261 1/20 0.36
CACNG8 Q8WXS5 1/20 0.36
CACNG2 Q9Y698 1/20 0.36
HTT P42858 2/20 0.36
MAPK1 P28482 1/20 0.36
ALDH1A1 P00352 7/20 0.35
SIRT2 Q8IXJ6 2/20 0.35
SIRT1 Q96EB6 2/20 0.35
RAB9A P51151 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
LMNA P02545 1/20 0.34
GAA P10253 1/20 0.34
PTGS2 P35354 1/20 0.34
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12247165 1.00 ESR1 (0.39) ESR1ESR2MAPK10RECQLPTGER4
SCHEMBL12247131 0.95 RECQL (0.38) ESR1ESR2MAPK10RECQLPTGER4
SCHEMBL18975544 0.95 PTGER4 (0.36) ESR1ESR2MAPK10RECQLPTGER4
SCHEMBL12247186 0.95 MAPK10 (0.39) ESR1ESR2MAPK10RECQLPTGER4
SCHEMBL12247064 0.95 ESR1 (0.38) ESR1ESR2MAPK10RECQLPTGER4
SCHEMBL12247169 0.95 MAPK10 (0.39) ESR1ESR2MAPK10RECQLPTGER4
SCHEMBL12247035 0.94 MAPK10 (0.40) ESR1ESR2MAPK10RECQLPTGER4
SCHEMBL12247290 0.94 ESR1 (0.43) ESR1ESR2RECQLPTGER4GRIA1
SCHEMBL12247144 0.94 ESR1 (0.41) ESR1ESR2RECQLPTGER4GRIA1
SCHEMBL12247161 0.94 ESR1 (0.41) ESR1ESR2RECQLPTGER4GRIA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8525158-B2 Anthracene derivative and organic electroluminescence element using the same DOOSAN CORPORATION (KR) 2013-09-03 US disclosed
US-8525158-B2 Anthracene derivative and organic electroluminescence element using the same DOOSAN CORPORATION (KR) 2013-09-03 US disclosed
US-20110210320-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING THE SAME DOOSAN CORPORATION (KR) 2011-09-01 US disclosed
US-20110210320-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING THE SAME DOOSAN CORPORATION (KR) 2011-09-01 US disclosed
WO-2010027181-A2 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING THE SAME 주식회사 두산 (KR) 2010-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110210320-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING THE SAME KCNJ2, KCNJ1, BRD4 ESR1 143/4885ESR2 686/4885MAPK10 2706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.